Faith groups urge White House to release $7 billion for HIV/AIDS
Five faith-based groups urged the White House to release $7 billion in congressionally approved HIV/AIDS funding for PEPFAR and the Global Fund, warning delays could disrupt treatment for millions. Wi
Five faith-based organizations have sent a letter to the White House urging the release of congressionally approved funding for global HIV/AIDS preven
Read Full Story at The Hill →Why This Matters
The funding dispute over PEPFAR and the Global Fund strikes at the heart of a 40-year battle against HIV/AIDS—a crisis that has claimed over 40 million lives and remains a global health priority. For faith-based organizations, which have historically played a pivotal role in HIV prevention and treatment, this appeal underscores the moral urgency of bipartisan commitments to public health, particularly in regions where religious institutions often fill gaps in healthcare access.
Background Context
PEPFAR (President’s Emergency Plan for AIDS Relief), launched in 2003 under George W. Bush, has been one of the most successful global health initiatives, saving an estimated 25 million lives and reducing new HIV infections by 50% in some countries. The Global Fund, a multilateral partnership, relies on U.S. contributions for nearly a third of its budget, making its operations directly tied to congressional appropriations. Delays in releasing funds create immediate risks for treatment programs in sub-Saharan Africa and other high-burden regions.
What Happens Next
If the White House does not disburse the $7 billion promptly, clinics may face stockouts of antiretroviral drugs, leading to increased mortality and new infections. The delay could also embolden critics of PEPFAR and the Global Fund, who argue for reallocating resources or tightening funding conditions tied to abortion-related policies. Congressional hearings and advocacy campaigns are likely to intensify, with faith groups amplifying their moral case as a counterbalance to political polarization.
Bigger Picture
This funding fight reflects a broader trend of declining U.S. leadership in global health, where long-standing bipartisan consensus on foreign aid is eroding. It also highlights the evolving role of faith-based organizations in global health governance, as they leverage moral authority to bridge ideological divides. With HIV/AIDS treatment now a decades-old success story, the debate also raises questions about whether the world’s response will sustain momentum—or risk backsliding in the face of competing priorities.
